AuctuCel launches AuctuPrime for cell therapy manufacturing
August 05, 2026 | 11:47
AuctuCel launched AuctuPrime, a chemically defined medium that removes animal serum and human platelet supplements, as Singapore anticipates roughly 19,290 new cancer cases in 2024 amid growing demand for advanced cell therapies.
Mobile Version